Insmed
INSM
171 hedge funds and large institutions have $3.24B invested in Insmed in 2019 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 83 increasing their positions, 34 reducing their positions, and 20 closing their positions.
144% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 34
75% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 20
38.78% more ownership
Funds ownership: 106.05% → 144.83% (+39%)
35% more capital invested
Capital invested by funds: $2.39B → $3.24B (+$846M)
8% more funds holding
Funds holding: 158 → 171 (+13)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
36% less call options, than puts
Call options by funds: $9.82M | Put options by funds: $15.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$864M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$47.7M |
| 3 |
D.E. Shaw & Co
New York
|
+$45.3M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$41.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$32.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$29M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$23.1M |
| 3 |
Millennium Management
New York
|
-$9.26M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.88M |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$5.44M |
INSM Hedge Fund Activity: Q2 2019 in Review
171 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2019, worth a combined $3.24B — up 35% from $2.39B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new INSM positions and 20 closed out — a net gain of 15 holders — while 83 added to existing stakes and 34 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $864M. The largest seller was Fidelity Investments, cutting an estimated $29M.
- 171 institutional investors held Insmed (INSM) as of Q2 2019, up from 158 in Q1 2019.
- Funds reported $3.24B of Insmed stock for Q2 2019, up 35% quarter-over-quarter.
- 35 funds opened new Insmed positions in Q2 2019 and 20 closed out, a net change of +15 holders.
- The largest Insmed buyer in Q2 2019 was Amundi Asset Management US, an estimated $864M added.
- The largest Insmed seller in Q2 2019 was Fidelity Investments, an estimated $29M sold.
Based on aggregated 13F filings for Q2 2019.